Cilostazol Tablet
Product Images NDC 70436-157

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 70436-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Cilostazol Figure1)

A pharmacokinetic line graph depicting plasma concentration (ng/mL) of Cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol over a 24-hour period (time in hours). The graph shows concentration decay curves for all three substances after administration.*

FDA Label Image

Chem-structure (Image 01)

Chemical structure diagram of cilostazol with molecular formula C20H27N5O2 and molecular weight 369.46.*

FDA Label Image

Figure2 (Image 02)

A bar chart comparing the percent mean improvement in maximum walking distance across eight clinical trials involving placebo, Cilostazol 50 mg b.i.d., and Cilostazol 100 mg b.i.d. The vertical axis shows percentage improvement, and the horizontal axis lists trial numbers with sample sizes and study durations noted. Cilostazol 100 mg generally shows higher improvement than the 50 mg dose and placebo across most trials.*

FDA Label Image

70436-156-06 (Image 03)

Cilostazol Tablets USP 50 mg oral tablets label from Slate Run Pharmaceuticals, LLC. The label indicates prescription use only, contains 60 tablets, and instructs dispensing with an attached patient information leaflet. Storage instructions specify 20° to 25°C (68° to 77°F). The label also includes manufacturer and distributor details, barcode, and a coating-free area for lot and serialization data.*

FDA Label Image

70436-157-06 (Image 04)

Packaging label for Cilostazol Tablets USP 100 mg oral tablets by Slate Run Pharmaceuticals, LLC. The label shows the product name, strength (100 mg), NDC 70436-157-06, quantity of 60 tablets, and directions to dispense with an attached patient information leaflet. Storage instructions and manufacturer details, including Yichang Humanwell Oral Solid Dosage Plant in China, are provided along with usual dosage information and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.